Cisapride Oral Suspension (Anhydrous)

How to Give Anhydrous Oral Suspension

Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:

1. Shake well each time to mix the medication (5-10 seconds).
2. Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
3. Hold your pet steady: a towel or helper can assist with squirmy pets.
4. Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
5. Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
6. Praise your pet and offer a treat or water (unless advised against feeding right after).
7. Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
8. Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.

The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.

Veterinarians most commonly consider cisapride for feline patients presented with chronic constipation or megacolon. It is also frequently a point of discussion for managing canine patients with esophageal reflux or localized delays in stomach emptying (gastroparesis). By enhancing the tone and coordination of the smooth muscles in the gut, your veterinarian can manage the transition of food and waste through the gastrointestinal system. At a pharmacological level, cisapride acts as a serotonin 5-HT4 receptor agonist and a 5-HT3 receptor antagonist. the stimulation of 5-HT4 receptors on the enteric neurons triggers the release of acetylcholine at the myenteric plexus. This increase in acetylcholine promotes the contraction of smooth muscle across the entire length of the digestive tract, including the esophagus, stomach and intestines. cisapride provides a advantage by influencing motility in the distal portions of the gut, such as the colon. Your veterinarian will determine the clinical appropriateness of cisapride based on diagnostic findings like radiographs or ultrasound.

Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.

Commonly observed effects following the administration of cisapride include localized digestive changes such as loose stools, diarrhea or abdominal discomfort. Some pets may exhibit behavioral shifts including lethargy or a decrease in appetite. Owners should monitor their pet for any unusual signs of abdominal pain or significant shifts in bowel habits and contact their veterinarian promptly with any concerns. This medication is typically used with extra caution or avoided in patients presented with a known gastrointestinal obstruction or perforation, as increased motility can be counterproductive in these cases. It is also carefully evaluated in pets with a history of cardiac arrhythmias or hepatic impairment. Significant interactions can occur if cisapride is administered concurrently with certain antifungal medications or macrolide antibiotics, as these combinations can influence the clearance of cisapride from the system. Your veterinarian is the right person to provide guidance on the necessary duration of use and to ensure the administration protocol is appropriately tailored to your pet's health status.